BSEVivanza Biosciences LtdMinimalNeutral
Announced Sat, 9 May · 11:56 IST

In terms of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find enclosed copy of newspaper advertisement published in English daily ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.0%1-day move
₹1.90
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0-2.6-3.7+2.1-3.7-4.7-4.7-10.5-1.1
Up moveDown movePending
AI summary

Vivanza Biosciences Ltd (BSE Code: 530057, ISIN: INE984E01035) has filed a disclosure under SEBI Regulation 47, informing BSE that the company published newspaper advertisements in The Indian Express (English) and Financial Express (Gujarati) containing the extract of its Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026. The filing was signed by Jayendra Amichand Mehta, Managing Director (DIN: 08210602), and submitted on May 9, 2026. The actual financial numbers are not included in the filing itself — they appeared in the published newspaper advertisements. This is a mandatory compliance filing under SEBI listing regulations requiring public disclosure of financial results.

Likely market impact

This is a routine regulatory compliance filing confirming that the company met its obligation to publish quarterly and annual financial results in newspapers as required by SEBI. No financial figures or qualitative commentary are provided in this notification. Shareholders should refer to the published newspaper advertisements for the actual financial performance details.